Zobrazeno 1 - 6
of 6
pro vyhledávání: '"TB Rodríguez-Cuadros"'
Publikováno v:
Eur J Hosp Pharm
Background Angiokeratomas are benign vascular skin lesions characterised by proliferation of dilated blood vessels in the upper dermis. Some variants have been described that can affect different regions of the body including face and genitals. They
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d25ac81a487ee27d0fdfb4a2e6cad8
https://doi.org/10.1136/ejhpharm-2018-eahpconf.234
https://doi.org/10.1136/ejhpharm-2018-eahpconf.234
Publikováno v:
Clinical pharmacy.
Background Retinopathy of prematurity (ROP) is a proliferative disease of the retinal vasculature that can cause severe visual loss in premature newborns. Intravitreal bevacizumab has shown promise as a treatment for ROP. Purpose To evaluate the effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65deb22f82e8dd04a99364495c1c4b4f
https://doi.org/10.1136/ejhpharm-2017-000640.22
https://doi.org/10.1136/ejhpharm-2017-000640.22
Autor:
F Verdejo Reche, P Nieto Guindo, D Fernández Ginés, TB Rodríguez Cuadros, F Sierra Garcia, I Alferez Garcia
Publikováno v:
European Journal of Hospital Pharmacy. 22:A92.1-A92
Background Refractory cancer pain is often difficult to manage. Ketamine is a drug with evidence of efficacy in the treatment of chronic cancer pain. Purpose To evaluate the efficacy and safety of ketamine rinse solution in paediatric patients with r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dafc13e9446309b46063989156e7d0a4
https://doi.org/10.1136/ejhpharm-2015-000639.220
https://doi.org/10.1136/ejhpharm-2015-000639.220
Publikováno v:
European Journal of Hospital Pharmacy. 22:A92.3-A93
Background Laser photocoagulation (LPC) is considered the standard treatment for retinopathy of prematurity (ROP), but LPC is destructive, causes complications, and does not prevent all vision loss. Recently, bevacizumab (a vascular endothelial growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3c598c2f6826dd64f1690aa21948960
https://doi.org/10.1136/ejhpharm-2015-000639.222
https://doi.org/10.1136/ejhpharm-2015-000639.222
Publikováno v:
European Journal of Hospital Pharmacy. 22:A94.1-A94
Background Hypercalcaemia can cause life-threatening complications. Pharmacological treatment of severe hypercalcaemia is complicated by lack of experience with some effective medicines such as bisphosphonates in newborns. Purpose To describe the pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::064976529123f480ae08d14fb778e93d
https://doi.org/10.1136/ejhpharm-2015-000639.226
https://doi.org/10.1136/ejhpharm-2015-000639.226
Autor:
JA Morales Molina, D Fernández Ginés, F Sierra Garcia, TB Rodríguez Cuadros, F Verdejo Reche, M Cortiñas Saenz, S. García Muñoz
Publikováno v:
European Journal of Hospital Pharmacy. 22:A120.3-A121
Background The use of an alternative liquid anaesthetic sevoflurane has recently been reported in the literature on vascular ulcers. Topical application for management of analgesia appears to be successful. Purpose To evaluate the stability of sevofl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74242cfc009aacfd7ab268d2d628f539
https://doi.org/10.1136/ejhpharm-2015-000639.294
https://doi.org/10.1136/ejhpharm-2015-000639.294